comparemela.com

Latest Breaking News On - Biocon group syngene international - Page 1 : comparemela.com

Large US Drug Makers Highlight Indian Market For Their Blockbuster Drugs Including For Weight Loss - Eli Lilly and Co (NYSE:LLY), Bristol-Myers Squibb (NYSE:BMY)

Eli Lilly's CEO, David Ricks, outlines plans to launch the obesity drug Tirzepatide in India next year, presenting opportunities amid competition from Novo Nordisk. Bristol Myers Squibb expands its R&D footprint, eyeing India as a pivotal hub for innovation and clinical trials.

Cancer drugmaker Bristol Myers to build its largest R&D facility outside US in India by 2025

The $100-million facility, inaugurated by Boerner on Monday, is expected to employ over 1,500 employees and will be used to enhance its drug development through the use of digital technologies and artificial intelligence, he said in his keynote speech at the BioAsia conference.

Bristol Myers CEO says India to have largest R&D presence outside US by 2025

Bristol Myers Squibb aims to expand its research and development presence in India and expects its newly inaugurated Hyderabad facility to become its largest unit outside the U.S. by 2025,.

Bristol Myers CEO says India to have largest R&D presence outside US by 2025 | Company News

Bristol Myers CEO says India to have largest R&D presence outside US by 2025 | Company News
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.